Alps Advisors Inc Ocugen, Inc. Transaction History

Alps Advisors Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$0.82 - $1.33 $381 - $618	465 Added 0.31%	149,176 $126,000
Q4 2022 Feb 14, 2023	BUY	$1.11 - $1.87 $33,833 - $56,999	30,481 Added 25.78%	148,711 $193,000
Q3 2022 Nov 14, 2022	SELL	$1.75 - $3.1 $16,975 - $30,070	-9,700 Reduced 7.58%	118,230 $210,000
Q2 2022 Aug 11, 2022	BUY	$1.83 - $3.45 $234,111 - $441,358	127,930 New	127,930 $290,000

123

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $169M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.